IL3 and acute myeloid leukemia: We also tested for the release of alternative cytokines other than G-CSF and detected a reduction in GM-CSF, IL-3, IL-6, and IL-1ß in individual AML models, but not consistently across all oncogenic drivers mutations (Fig. S4A).